Clinical Trials
64 trialsCASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Masonic Cancer Center, University of Minnesota
PREDICT
Alliance for Clinical Trials in Oncology
XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Xencor, Inc.
CABA-GCT
Gustave Roussy, Cancer Campus, Grand Paris
CHAMP
Duke University
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Eastern Cooperative Oncology Group
Bristol Bladder Trial
University Hospitals Bristol and Weston NHS Foundation Trust
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
M.D. Anderson Cancer Center
Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC
M.D. Anderson Cancer Center
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
University of Michigan Rogel Cancer Center
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer
M.D. Anderson Cancer Center
CheckMate 650
Bristol-Myers Squibb
CATCH-177
Case Comprehensive Cancer Center
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
Thomas Jefferson University
CABPOSTAAT
Centre hospitalier de l'Université de Montréal (CHUM)
A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer
Jina Pharmaceuticals Inc.
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer
Memorial Sloan Kettering Cancer Center
DAROTAXEL
Erasmus Medical Center
PEAPOD_FOS
Fundacion Oncosur
Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
Icahn School of Medicine at Mount Sinai
Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
University Hospital, Akershus
ACDC-RP
University Health Network, Toronto
AARDVARC
AstraZeneca
JAVA-P
University Hospitals Bristol and Weston NHS Foundation Trust
TheraP
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Cabazitaxel and Radiation For Patients With Prostate Cancer
Brown University
TACTIK
UNICANCER
Ph II Cabazitaxel DD Liposarcoma
European Organisation for Research and Treatment of Cancer - EORTC
CABA-V7
Erasmus Medical Center
ORL03
UNICANCER
Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
University of California, Davis
CHROME
The Clatterbridge Cancer Centre NHS Foundation Trust
CaTo-ROC
Vejle Hospital
CABA-BONE
Hellenic Cooperative Oncology Group
CONCEPT
University Hospitals Bristol and Weston NHS Foundation Trust
PRIMCAB
Sanofi
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen
Brown University
Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer
University of Colorado, Denver
Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
CabACC
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma
Weill Medical College of Cornell University
CaBaMet
AIO-Studien-gGmbH
CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy
Consorzio Oncotech
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
British Columbia Cancer Agency
TAXYNERGY
Sanofi
Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme
University of Ulm
Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes
Hellenic Cooperative Oncology Group
Study of Weekly Cabazitaxel for Advanced Prostate Cancer
Spanish Oncology Genito-Urinary Group
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
SCRI Development Innovations, LLC
RACATREX
Cliniques universitaires Saint-Luc- Université Catholique de Louvain